| Literature DB >> 28276630 |
Agnieszka Gawin1, Svein Valla1, Trygve Brautaset1.
Abstract
The XylS/Pm regulator/promoter system originating from the Pseudomonas putida TOL plasmid pWW0 is widely used for regulated low- and high-level recombinant expression of genes and gene clusters in Escherichia coli and other bacteria. Induction of this system can be graded by using different cheap benzoic acid derivatives, which enter cells by passive diffusion, operate in a dose-dependent manner and are typically not metabolized by the host cells. Combinatorial mutagenesis and selection using the bla gene encoding β-lactamase as a reporter have demonstrated that the Pm promoter, the DNA sequence corresponding to the 5' untranslated end of its cognate mRNA and the xylS coding region can be modified and improved relative to various types of applications. By combining such mutant genetic elements, altered and extended expression profiles were achieved. Due to their unique properties, obtained systems serve as a genetic toolbox valuable for heterologous protein production and metabolic engineering, as well as for basic studies aiming at understanding fundamental parameters affecting bacterial gene expression. The approaches used to modify XylS/Pm should be adaptable for similar improvements also of other microbial expression systems. In this review, we summarize constructions, characteristics, refinements and applications of expression tools using the XylS/Pm system.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28276630 PMCID: PMC5481539 DOI: 10.1111/1751-7915.12701
Source DB: PubMed Journal: Microb Biotechnol ISSN: 1751-7915 Impact factor: 5.813
Figure 1The upper scheme illustrates the catabolic operon for degradation of aromatic compounds in the Pseudomonas putida TOL plasmid pWW0. The upper‐pathway operon is under transcriptional control of XylR/Pu and encodes enzymes that transform toluene into benzoate. Subsequently, benzoate is converted to tricarboxylic acid (TCA) intermediates by enzymes encoded in the meta‐pathway operon, under transcriptional control of XylS/Pm. Circles, XylR; triangles, XylS; open symbols, regulator unable to activate transcription; solid symbols, regulator able to stimulate transcription; +, activating effect; −, repressing effect (Inouye et al., 1987; Greated et al., 2002). The lower part of the figure presents how XylS/Pm can be applied to express recombinant genes. Pm is activated by the XylS regulator when it forms a complex with a meta‐pathway substrate entering passively into the cell.
Figure 2Schematic model of Pm activation. XylS binding sites and the ‐10/‐35 consensus sequences for binding RNA polymerase are indicated. As a result of the interactions between XylS monomers and the Pm region, the DNA curvature increases to an overall of 98° (González‐Pérez et al., 1999, 2002; Domínguez‐Cuevas et al., 2010).
Reported XylS effectors and their induction ratios
| Inducer | Induction ratios | Selected references |
|---|---|---|
| 3‐methylbenzoate (m‐toluate) | 17–600 | Mermod |
| Salicylate | 15–292 | Ramos |
| Acetyl salicylic acid (ASA) | 20–150 | Royo |
| 3‐methylsalicylate | 46–72 | Ramos |
| 5‐methoxysalicylate | 46 | Cebolla |
| Benzoate | 44 | Ramos |
| 2‐methylbenzoate | 18–29 | Ramos |
| 4‐chlorobenzoate | 5–26 | Ramos |
| 4‐ methoxybenzoate | 1–23 | Ramos |
| 3‐chlorobenzoate | 11–22 | Ramos |
| 4‐methylbenzoate | 4–21 | Ramos |
| 5‐methylsalicylate | 19 | Cebolla |
| 2‐chlorobenzoate | 14–18 | Ramos |
| 2,3‐dimethylbenzoate | 10–18 | Ramos |
| 2‐methoxybenzoate | 1–17 | Ramos |
| 3‐fluorobenzoate | 8–16 | Ramos |
| 2‐fluorobenzoate | 4–15 | Ramos |
| 4‐ethylbenzoate | 1–15 | Ramos |
| 3‐bromobenzoate | 12–14 | Ramos |
| 4‐fluorobenzoate | 4–14 | Ramos |
| 4‐bromobenzoate | 1–14 | Ramos |
| 2,5‐dimethylbenzoate | 1–13 | Ramos |
| 3,4‐dichlorobenzoate | 4–12 | Ramos |
| anthranilate | 11 | Cebolla |
| 2‐acetylsalicylate | 10 | Cebolla |
| 3‐iodobenzoate | 5–9 | Ramos |
| 4‐iodobenzoate | 1–9 | Ramos |
| 3‐ methoxybenzoate | 1–8 | Ramos |
| 3,4‐dimethylbenzoate | 5–7 | Ramos |
| 2‐bromobenzoate | 1–7 | Ramos |
| 4‐methylsalicylate | 7 | Cebolla |
The following compounds promoted no induction of the XylS/Pm or the induction ratios were not reported: 2,3‐dichlorobenzoate (Liu et al., 2010), 3,5‐dichlorobenzoate (Ramos et al., 1990a; Michan et al., 1992a; Liu et al., 2010), sodium benzoate (Purvanov and Fetzner, 2005), 5‐chlorosalicylate, 4‐chlorosalicylate, 3,5‐dichlorosalicylate (Cebolla et al., 2002), 2,4‐dimethylbenzoate (Ramos et al., 1990a; Zhou et al., 1990; Michan et al., 1992a), 2,6‐dichlorobenzoate (Ramos et al., 1990a; Michan et al., 1992a), 3,5‐dimethylbenzoate (Ramos et al., 1990a; Zhou et al., 1990), 2,6‐difluorobenzoate, 2‐iodobenzoate, 2,4‐dichlorobenzoate, 3‐hydroxybenzoate, 4‐hydroxybenzoate, 2,5‐dichlorobenzoate (Ramos et al., 1990a), 2,6‐dimethylbenzoate (Zhou et al., 1990), m‐xylene, o‐chlorotoluene, p‐ethyltoluene, 1,2,3‐trimethylbenzene, 1,3,4‐trimethylbenzene, 2,5‐dichlorotoluene, 2,6‐dichlorotoluene, benzyl alcohol, p‐methylbenzyl alcohol, p‐ethylbenzyl alcohol, m‐chlorobenzyl alcohol (Abril et al., 1989).
a. The ratio of the induced/basal expression. Induction was performed by using inducers at a concentration between 0, 1 and 5 mM (in most cases 1 or 2 mM).
b. The activity of indicated inducer or presented induction ratio was reported for the mutagenized form of XylS protein.
Figure 3Vectors for combinatorial mutagenesis of various expression elements using bla as reporter gene for antibiotic tolerance level selection.
A. Vector tool for mutagenesis and selection using bla (encoding β‐lactamase) as a reporter gene. The Pm promoter coding region, the Pm 5′‐UTR coding region and the xylS coding region can individually be substituted by libraries of randomly mutagenized oligonucleotides and genes. The libraries were made by synthesizing one mutated strand for each of the three regions. During synthesis of these strands, the three alternative nucleotides were mixed at a varying percentage (for example, 4% each) with the nucleotide of the wild‐type strand. The bases to be mutagenized were varied in different libraries. After synthesis, the DNA strands were annealed to their respective non‐mutagenized complementary strands (Winther‐Larsen et al., 2000b; Bakke et al., 2009). Cloning was then done by using the relevant restriction endonuclease sites indicated on the figure. Up and down mutants can be directly selected by growing the recombinant cells on different ampicillin concentrations. T is a transcriptional terminator.
B. Vector tool for selection of 5′‐UTR mutants based on translational re‐initiation. The gene of interest (goi) is placed under control of Pm and the bla coding gene with its translational start codon overlaps with the goi stop codon (TGATG). Construction of mutant libraries of the Pm 5′‐UTR coding region and screening for increased ampicillin resistance relative to wild‐type was done as described in A above.
Host organisms used for the XylS/Pm‐mediated expression of heterologous proteins and examples of applications in these hosts
| Host organism | Applications and characteristics | Selected references |
|---|---|---|
|
| Assay of catechol 2,3‐dioxygenase activities | Mermod |
|
| Assay of catechol 2,3‐dioxygenase activities | Mermod |
|
| Assay of β‐galactosidase and catechol 2,3‐dioxygenase activities | Ramos |
|
| Targetrons expression, assay of catechol 2,3‐dioxygenase activities; high‐level expression | Mermod |
|
| Assay of catechol 2,3‐dioxygenase activities | Mermod |
|
| Over‐expression of NifH (Fe protein), AlgE3 expression, assay of β‐galactosidase activities | Steigedal |
|
| Mutant strains generation and evaluation; high‐level, tightly controlled expression, versatility | Ortiz‐Román |
|
|
| Sasoh |
|
| Assay of catechol 2,3‐dioxygenase activities | Mermod |
|
|
| Yao and Lambowitz ( |
|
| Assay of catechol 2,3‐dioxygenase activities | Mermod |
|
| Assay of catechol 2,3‐dioxygenase activities | Mermod |
|
| Assay of catechol 2,3‐dioxygenase activities | Mermod |
|
| Adaptation of the XylS/ | Dragset |
|
| Adaptation of the XylS/ | Dragset |
|
| Myxothiazol gene cluster expression | Perlova |
|
| Assay of catechol 2,3‐dioxygenase activities | Mermod |
|
| Expression of genes involved in biofilm‐specific antibiotic resistance, expression of genes involved in ethanol oxidation, targetrons expression, 3‐oxosteroid D1‐dehydrogenase gene expression, over‐expression of | Bell |
|
|
| Yang |
|
|
| Casaz |
|
| Polyhydroxyalkanoate production; stable regulation | Prieto |
|
| Minitransposon delivery vector construction, recombinant antibody fragments production, I‐SceI genomic deletions system, quinoline 2‐oxidoreductase expression, metallothioneins production; expression of firefly luciferase genes tight control, low cost | Purvanov and Fetzner ( |
|
| Different fusion proteins expression, expression of lysis gene E | Kloos |
|
| Different fusion proteins expression | Gross |
|
| I‐SceI genomic deletions system; tight control | Volmer |
|
| Assay of catechol 2,3‐dioxygenase activities | Mermod |
|
| Development of genetic toolbox for | Valls |
|
| Cytosine deaminase expression, virulescence factor expression, | Royo |
|
| Assay of catechol 2,3‐dioxygenase activities | Mermod |
|
| Assay of β‐galactosidase activities | Ramos |
|
| Suicide system control; tight regulation | Lan |
|
| Expression of lysis gene E | Eko |
|
| Phosphoglucomutase expression, assay of catechol 2,3‐dioxygenase activities; high‐level expression, tight regulation | Mermod |